Clinical Trial: Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Long-Term Tolerability and Safety of Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) for the Treatment of Chronic Inflammatory Demyelinating